Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
At the six-month mark, I was down to 148 pounds
Routine check-ins with care teams are critical
If you are overweight or obese (with a BMI of 25 or higher) or have one or more obesity-related conditions, you may be a suitable candidate for GLP-1 therapy
To illustrate how storage requirements vary between licensed peptide medicines, and why extrapolation is unreliable: Semaglutide (Ozempic, Wegovy) according to the respective Summaries of Product Characteristics (SmPCs) on the Electronic Medicines Compendium (EMC), these products may be stored below 30C for a defined period after first use, but conditions differ between formulations Liraglutide (Saxenda) the SmPC specifies a different room-temperature allowance and duration Tirzepatide (Mounjaro) a dual GIP/GLP-1 agonist with its own distinct storage instructions [11] [12] These examples demonstrate that even closely related agents have product-specific requirements that cannot be applied to retatrutide
